MORGAN LOUVIERE: Open Payments
NPI 1528481744 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 8 payments from 6 companies in 2025. Trend: 2023 $265 · 2024 $407 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $122 |
| Abbott Laboratories | 2 | $103 |
| ABBVIE INC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: ARISTADA, FREESTYLE LIBRE 3, UBRELVY, ENTRESTO, CAPLYTA, QULIPTA, AREXVY.
Industry payments across LA — which companies pay providers there.
